Future research focusing on upstream regulatory mechanisms, including epigenetic modifications, such as histone methylation and DNA/RNA methylation, may provide deeper insights into PAD4′s role in T1DM and inform new therapeutic strategies. This evidence concerns the gene PADI4 and type 1 diabetes mellitus.